LU72306A1 - - Google Patents

Info

Publication number
LU72306A1
LU72306A1 LU72306A LU72306A LU72306A1 LU 72306 A1 LU72306 A1 LU 72306A1 LU 72306 A LU72306 A LU 72306A LU 72306 A LU72306 A LU 72306A LU 72306 A1 LU72306 A1 LU 72306A1
Authority
LU
Luxembourg
Application number
LU72306A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU72306A1 publication Critical patent/LU72306A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU72306A 1974-04-17 1975-04-17 LU72306A1 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
LU72306A1 true LU72306A1 (xx) 1976-03-17

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
LU72306A LU72306A1 (xx) 1974-04-17 1975-04-17

Country Status (21)

Country Link
US (1) US4009847A (xx)
JP (1) JPS50148349A (xx)
AR (1) AR208545A1 (xx)
CA (1) CA1047042A (xx)
CH (1) CH611292A5 (xx)
DD (1) DD117223A5 (xx)
DE (1) DE2516554A1 (xx)
DK (1) DK164175A (xx)
ES (1) ES436648A1 (xx)
FI (1) FI751128A (xx)
FR (1) FR2267773B1 (xx)
GB (1) GB1461209A (xx)
HU (1) HU173052B (xx)
IE (1) IE41143B1 (xx)
IL (1) IL47095A (xx)
LU (1) LU72306A1 (xx)
NL (1) NL7504570A (xx)
NO (1) NO144071C (xx)
PH (1) PH11722A (xx)
SE (1) SE417965B (xx)
YU (1) YU96075A (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
ATE556713T1 (de) * 1999-01-13 2012-05-15 Bayer Healthcare Llc Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer
RU2319693C9 (ru) 1999-01-13 2008-08-20 Байер Копэрейшн Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
WO2000042012A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US8124630B2 (en) * 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
ES2275931T5 (es) * 2001-12-03 2018-10-23 Bayer Healthcare Llc Compuestos de aril-urea en combinación con otros agentes citostáticos o citotóxicos para tratamiento de cánceres humanos
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
SI1478358T1 (sl) * 2002-02-11 2013-09-30 Bayer Healthcare Llc Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
WO2003068223A1 (en) * 2002-02-11 2003-08-21 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
WO2003068229A1 (en) * 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
CA2475818C (en) * 2002-02-11 2011-07-19 Bayer Pharmaceuticals Corporation Aryl ureas as kinase inhibitors
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
PT1626714E (pt) * 2003-05-20 2007-08-24 Bayer Pharmaceuticals Corp Diarilureias para doenças mediadas por pdgfr
EA010485B1 (ru) * 2003-07-23 2008-10-30 Байер Фамэсьютиклс Копэрейшн Производное n,n'-дифенилмочевины, фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с его использованием (варианты)
WO2005110994A2 (en) * 2004-04-30 2005-11-24 Bayer Pharmaceuticals Corporation Substituted pyrazolyl urea derivatives useful in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
NL7504570A (nl) 1975-10-21
HU173052B (hu) 1979-02-28
AR208545A1 (es) 1977-02-15
GB1461209A (en) 1977-01-13
FI751128A (xx) 1975-10-18
DK164175A (da) 1975-10-18
CA1047042A (en) 1979-01-23
PH11722A (en) 1978-05-30
YU96075A (en) 1983-04-27
DD117223A5 (xx) 1976-01-05
CH611292A5 (xx) 1979-05-31
IL47095A0 (en) 1975-06-25
SE7503523L (sv) 1975-10-20
NO144071C (no) 1981-06-17
SE417965B (sv) 1981-04-27
IE41143L (en) 1975-10-17
DE2516554A1 (de) 1975-10-30
JPS50148349A (xx) 1975-11-27
IL47095A (en) 1978-03-10
NO144071B (no) 1981-03-09
NO751351L (xx) 1975-10-20
ES436648A1 (es) 1977-08-01
FR2267773B1 (xx) 1978-08-18
FR2267773A1 (xx) 1975-11-14
IE41143B1 (en) 1979-10-24
US4009847A (en) 1977-03-01
AU8013575A (en) 1976-10-21

Similar Documents

Publication Publication Date Title
FR2267773B1 (xx)
FR2264615B1 (xx)
JPS50101563A (xx)
JPS50114017A (xx)
FR2294081B1 (xx)
JPS50112995A (xx)
FR2270807B1 (xx)
JPS50102033U (xx)
JPS50112210U (xx)
JPS50116380U (xx)
JPS50104584U (xx)
BG21784A1 (xx)
BG23489A1 (xx)
BG20855A2 (xx)
BG20643A1 (xx)
BG20460A1 (xx)
CH573571A5 (xx)
BG21119A1 (xx)
CH573044A5 (xx)
BG20444A1 (xx)
BG21787A1 (xx)
BG22207A1 (xx)
BG22501A1 (xx)
BG22732A1 (xx)
CH573783A5 (xx)